Cargando…
Effects of Delivering Guanidinoacetic Acid or Its Prodrug to the Neural Tissue: Possible Relevance for Creatine Transporter Deficiency
The creatine precursor guanidinoacetate (GAA) was used as a dietary supplement in humans with no adverse events. Nevertheless, it has been suggested that GAA is epileptogenic or toxic to the nervous system. However, increased GAA content in rodents affected by guanidinoacetate methyltransferase (GAM...
Autores principales: | Adriano, Enrico, Salis, Annalisa, Damonte, Gianluca, Millo, Enrico, Balestrino, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773658/ https://www.ncbi.nlm.nih.gov/pubmed/35053827 http://dx.doi.org/10.3390/brainsci12010085 |
Ejemplares similares
-
Creatine salts provide neuroprotection even after partial impairment of the creatine transporter
por: Adriano, E., et al.
Publicado: (2017) -
Lack of Epileptogenic Effects of the Creatine Precursor Guanidinoacetic Acid on Neuronal Cultures In Vitro
por: Poggio, Fabio, et al.
Publicado: (2022) -
Processing mechanism of guanidinoacetate in choroid plexus epithelial cells: conversion of guanidinoacetate to creatine via guanidinoacetate N-methyltransferase and monocarboxylate transporter 12-mediated creatine release into the CSF
por: Jomura, Ryuta, et al.
Publicado: (2022) -
Creatine as a Candidate to Prevent Statin Myopathy
por: Balestrino, Maurizio, et al.
Publicado: (2019) -
Case Series of Creatine Deficiency Syndrome due to Guanidinoacetate Methyltransferase Deficiency
por: Narayan, Vinu, et al.
Publicado: (2020)